Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, Wayne State University, Detroit, MI.
Division of Endocrinology, Wayne State University School of Medicine, Wayne State University, Detroit, MI.
J Clin Endocrinol Metab. 2020 Mar 1;105(3):644-59. doi: 10.1210/clinem/dgz115.
Obesity-related insulin resistance (OIR) is one of the main contributors to type 2 diabetes and other metabolic diseases. Protein kinases are implicated in insulin signaling and glucose metabolism. Molecular mechanisms underlying OIR involving global kinase activities remain incompletely understood.
To investigate abnormal kinase activity associated with OIR in human skeletal muscle.
Utilization of stable isotopic labeling-based quantitative proteomics combined with affinity-based active enzyme probes to profile in vivo kinase activity in skeletal muscle from lean control (Lean) and OIR participants.
A total of 16 nondiabetic adults, 8 Lean and 8 with OIR, underwent hyperinsulinemic-euglycemic clamp with muscle biopsy.
We identified the first active kinome, comprising 54 active protein kinases, in human skeletal muscle. The activities of 23 kinases were different in OIR muscle compared with Lean muscle (11 hyper- and 12 hypo-active), while their protein abundance was the same between the 2 groups. The activities of multiple kinases involved in adenosine monophosphate-activated protein kinase (AMPK) and p38 signaling were lower in OIR compared with Lean. On the contrary, multiple kinases in the c-Jun N-terminal kinase (JNK) signaling pathway exhibited higher activity in OIR vs Lean. The kinase-substrate-prediction based on experimental data further confirmed a potential downregulation of insulin signaling (eg, inhibited phosphorylation of insulin receptor substrate-1 and AKT1/2).
These findings provide a global view of the kinome activity in OIR and Lean muscle, pinpoint novel specific impairment in kinase activities in signaling pathways important for skeletal muscle insulin resistance, and may provide potential drug targets (ie, abnormal kinase activities) to prevent and/or reverse skeletal muscle insulin resistance in humans.
肥胖相关的胰岛素抵抗(OIR)是 2 型糖尿病和其他代谢性疾病的主要原因之一。蛋白激酶参与胰岛素信号和葡萄糖代谢。涉及整体激酶活性的 OIR 的分子机制尚不完全清楚。
研究与人类骨骼肌 OIR 相关的异常激酶活性。
利用基于稳定同位素标记的定量蛋白质组学结合亲和活性酶探针,分析来自瘦对照组(Lean)和 OIR 参与者的骨骼肌中的体内激酶活性。
共 16 名非糖尿病成年人,8 名 Lean 和 8 名 OIR,进行高胰岛素-正常血糖钳夹术,同时进行肌肉活检。
我们鉴定了人类骨骼肌中的第一个活性激酶组,包含 54 种活性蛋白激酶。与 Lean 肌肉相比,OIR 肌肉中有 23 种激酶的活性不同(11 种高活性和 12 种低活性),而两组之间的蛋白丰度相同。AMPK 和 p38 信号通路中多个激酶的活性在 OIR 中低于 Lean。相反,JNK 信号通路中的多个激酶在 OIR 中比 Lean 更活跃。基于实验数据的激酶-底物预测进一步证实了胰岛素信号的潜在下调(例如,胰岛素受体底物-1 和 AKT1/2 的磷酸化受到抑制)。
这些发现提供了 OIR 和 Lean 肌肉中激酶组活性的全面视图,指出了对骨骼肌胰岛素抵抗重要的信号通路中激酶活性的新的特定损伤,并可能为预防和/或逆转人类骨骼肌胰岛素抵抗提供潜在的药物靶点(即异常激酶活性)。